Main > ENDOCRINOLOGY > Diabetes. Treatment > Glycogen Phosphorylase Inhibitors > Patent > Claims > Claim 1: Compd of Formula STR28 > Claim 5: 5-Acetyl-1-Et-2-Oxo-2,3-Di > -H-1H-Indole-3-Carboxylic Acid (3-p > -TolylCarbamoyl-Ph)-Amide Etc.



-TolylCarbamoyl-Ph)-Amide Etc.'s subsections
Claim 11: Diabetes Treat. Claim 22:

-TolylCarbamoyl-Ph)-Amide Etc.'s products
This section has no products